Workflow
维昇药业-B(02561)：陆楹已获委任为首席财务官
VISEN PHARMAVISEN PHARMA(HK:02561) 智通财经网·2025-10-13 09:58

Core Viewpoint - Vison Pharmaceutical-B (02561) announced the appointment of Lu Ying as the Chief Financial Officer, effective from October 13, 2025 [1] Group 1 - Lu Ying has been appointed as the Chief Financial Officer of Vison Pharmaceutical-B [1]